封面
市場調查報告書
商品編碼
1087040

全球組織銀行市場預測(2022-2027)

Tissue Banking Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球組織銀行市場預計將從 2020 年的 24.54 億美元增長到 2027 年的 33.74 億美元,預測期內的複合年增長率為 4.65%。

研發部門的新鮮樣本和組織需求為全球組織銀行市場的增長提供了潛力。此外,市場公司對細胞和組織再生領域的開發和研究的投資,以及依賴組織庫的醫院和衛生研究機構正在支持全球組織庫市場的增長。此外,越來越多的慢性病病例和基於組織再生的治療也增加了組織庫在全球市場的市場價值。此外,政府和政府的支持正在促進全球組織銀行市場的增長。

本報告研究和分析全球組織銀行市場,並提供市場概況、市場動態、市場分析、競爭形勢和公司概況等系統信息。

目錄

第一章介紹

  • 市場定義
  • 市場細分

第二章調查方法

  • 調查數據
  • 先決條件

第 3 章執行摘要

  • 調查重點

第四章市場動態

  • 市場促進因素
  • 市場製約因素
  • 波特五力分析
    • 終端用戶議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代威脅
    • 業內競爭對手之間的敵對關係
  • 產業價值鏈分析

第 5 章世界組織銀行業市場分析:按組織類型

  • 簡介
  • 角膜
  • 皮膚
  • 骨頭
  • 心臟瓣膜
  • 軟組織
  • 臍帶

第 6 章世界銀行銀行市場分析:按用途

  • 簡介
  • 治療
  • 研發
  • 其他

第 7 章世界銀行銀行市場分析:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印度尼西亞
    • 其他

第8章競爭環境與分析

  • 主要公司及戰略分析
  • 初創企業和市場盈利能力
  • 合併/收購/協議/聯盟
  • 供應商競爭矩陣

第 9 章公司簡介

  • Hamilton Company
  • IMA Pharma
  • Life Link Tissue Bank
  • Merck KgaA
  • PHC Europe B.V.
  • Tata Memorial Hospital-Tissue Bank
  • Tecan Group Ltd.
  • The PXE International Blood and Tissue Bank
  • Thermo Fisher Scientific, Inc.
  • TuBaFrost Group
  • Versity
簡介目錄
Product Code: KSI061612978

The global tissue banking market is evaluated at US$2.454 billion for the year 2020 and is projected to grow at a CAGR of 4.65% to reach a market size of US$3.374 billion by the year 2027.

A tissue bank is considered a certain type of bank that collects fresh specimens and tissue for future needs. The tissue bank is considered one of the leading specimen or tissue storage systems in the world. The medical field and research and development sectors are presently widely seeking the application and help of tissue banks. The need for fresh specimens and tissues in the research and development sector is giving potential to the growth of the global tissue bank market. The market players' investment in the development and research in the cell and tissue regeneration field are also driving the growth of the global tissue bank market. The medical sector and hospitals are also widely seeking the support and assistance of tissue banks for the treatment of certain chronic disorders. Hospitals and health research institutions relying on tissue banks are boosting the market growth of global tissue banks. The rising cases of chronic diseases like cancer etc. and their treatment based on tissue regeneration are also boosting the market value of tissue banks in the global market. The support offered by governments and government organizations is also contributing to the growth of the global tissue banking market.

The recent outbreak of the COVID-19 pandemic has adversely affected the market growth of the global tissue banking market. The ongoing research and developments conducted on tissues were halted due to the lockdowns and strict COVID-19 restrictions imposed by the government in order to prevent the spread of the coronavirus. The focus of the government and the medical field on preventing COVID spread resulted in less focus on and slow growth of the global tissue banking market in the pandemic period. The limited availability of practitioners and employees in the tissue banking sector also restricted the growth of the global tissue banking market to a certain extent. The high economic crisis that arose due to the COVID-19 pandemic also negatively influenced the economic stability of countries, restricting the growth of the tissue banking sector in each country, as the tissue banking systems have high expenditure and maintenance costs.

The demand for tissues for the treatment of chronic diseases

The rising demand for tissues for treating chronic diseases is increasing the market value of the global tissue banking sector. A tissue bank is a collection of various specimens and fresh tissues and is a relatively new discovery in the medical field that employs tissue for the treatment of chronic diseases and is boosting the growth of the global tissue banking system. According to the "American Association of Tissue Banks", the tissue banking network in the United States is exhibiting steady growth, with approximately 58 accredited tissue banks working in the United States alone. The tissue banks working in the United States are also properly certified and accredited by the FDA (Food and Drug Administration) of the United States. The government of the U.S. has been encouraging the use of tissue banks. According to the report of AATB (American Association of Tissue Banks), blood tissues or blood cells account for the major share of the global tissue banking market. The need for fresh specimens and the tissue in the treatment of chronic disorders and regeneration of tissue cells is driving the growth of the global tissue banking market.

Rising research and development

The growing trend of research and developments in tissue regeneration and the use of tissue in efficiently treating chronic diseases is boosting the growth of the global tissue banking market. Discoveries of stem cells in developing any other tissue is one of the latest innovations in the medical or health research sector. The discoveries like stem cells and others are fuelling the market growth of tissue banking in the global market. The investment of major players like Allergan and Hamilton Companies is boosting the applications and developments in tissue engineering. The wide research and developments in tissue engineering and employing tissue for treating chronic diseases are contributing to the market growth.

North America has the largest market share

Geographically, the North American region is has the largest share in the global tissue banking market. The presence of a large number of tissue banks and increasing research and development in the tissue engineering sector is leading to growth in the North American region in the tissue banking market. The presence of major market players and the rising number of chronic diseases are also driving the market growth in the North American tissue banking market.

Market Segmentation

  • By Tissue Type

Cornea

Skin

Bones

Heart Valves

Blood

Soft Tissues

Umbilical Cord

  • By Application

Therapeutic

Research and development

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Tissue Banking Market Analysis, by Tissue Type

  • 5.1. Introduction
  • 5.2. Cornea
  • 5.3. Skin
  • 5.4. Bones
  • 5.5. Heart Valves
  • 5.6. Blood
  • 5.7. Soft Tissues
  • 5.8. Umbilical Cord

6. Global Tissue Banking Market Analysis, by Application 

  • 6.1. Introduction
  • 6.2. Therapeutic
  • 6.3. Research and development
  • 6.4. Others

7. Global Tissue Banking Market Analysis, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. UK
    • 7.4.4. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles 

  • 9.1. Hamilton Company
  • 9.2. IMA Pharma
  • 9.3. Life Link Tissue Bank
  • 9.4. Merck KgaA
  • 9.5. PHC Europe B.V.
  • 9.6. Tata Memorial Hospital - Tissue Bank
  • 9.7. Tecan Group Ltd.
  • 9.8. The PXE International Blood and Tissue Bank
  • 9.9. Thermo Fisher Scientific, Inc.
  • 9.10. TuBaFrost Group
  • 9.11. Versity